
|Slideshows|March 6, 2017
Neuro News Roundup: Parkinson or parkinsonian?
Author(s)Mark L. Fuerst
Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.
Advertisement
The highlights of new studies in neurology include: a single dose of aspirin, from 500 mg to 1000 mg, may reduce the use of rescue medications in adults with frequent episodic tension-type headache; blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease and atypical parkinsonian disorder; and about half of patients with aggressive, treatment-refractory multiple sclerosis (MS) are free from neurological progression five years after autologous hematopoietic stem cell transplantation (AHSCT).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
TEMPO-2 Data Supports Tavapadon’s Efficacy in Early-Stage Parkinson Disease
2
AMO Pharma Aligns With Regulators on Registrational Study for AMO-02 in Myotonic Dystrophy
3
FDA Accepts Ecopipam NDA for Tourette Syndrome, Remlifanserin Receives Fast Track Designation for AD Psychosis, Alterity Reaches FDA Alignment on ATH434
4
FDA Clears PrecivityAD2 Alzheimer Blood Test for Symptomatic Patients 40 and Older
5

















